Related Experiment Video
Updated: Nov 6, 2025

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
Published on: November 10, 2023
Recent advances in prodrug-based nanoparticle therapeutics
Kuan-Ju Chen1, Adam J Plaunt1, Franziska G Leifer1
1Insmed Incorporated, Bridgewater, NJ, USA.
Prodrug-based nanoparticle drug delivery systems (PNDDS) combine prodrugs and nanoparticles to improve drug properties. This review details PNDDS development for advanced nanomedicine and novel therapies.
Area of Science:
- Pharmaceutical Sciences
- Nanomedicine
- Drug Delivery
Background:
- Prodrug modification and nanoparticle systems offer enhanced drug control.
- Prodrug-based nanoparticle drug delivery systems (PNDDS) represent an advanced approach in nanomedicine.
- PNDDS are increasingly relevant with many in clinical development.
Purpose of the Study:
- To introduce prodrug-based nanoparticle drug delivery systems (PNDDS) to new readers.
- To provide a comprehensive summary of recent advancements in PNDDS.
- To highlight the potential of PNDDS for treating difficult diseases.
Main Methods:
- Overview of FDA-approved prodrugs and their advantages.
- Brief introduction to nanoparticle drug delivery systems.
- Detailed discussion of rationally designed PNDDS formulations in development.
Main Results:
- Prodrugs offer advantages over traditional small molecule drugs.
- Nanoparticle systems have shown successful applications and unmet needs.
- Designed PNDDS leverage combined strengths for effective therapeutic options.
Conclusions:
- PNDDS integration advances nanomedicine.
- Rationally designed PNDDS show promise for treating various diseases.
- The field of PNDDS is rapidly evolving with significant therapeutic potential.
Related Concept Videos
Prodrugs
Prodrugs help overcome...
Bioavailability Enhancement: Drug Permeability Enhancement
Drug Discovery: Overview
Microorganisms in Medicine and Therapeutics
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

